Clinical trial
Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults
NCT00398125 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00398125 |
|---|---|
| Title | Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults |
| Official title | A Phase 2a, Multicenter, Randomized, Parallel, Double-Blind, Dose Ranging, Placebo-Controlled Study to Compare Antiviral Effect, Safety, Tolerability and Pharmacokinetics of GSK364735 Monotherapy Versus Placebo Over 10 Days in HIV-1 Infected Adults. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus, HIV-1 Infection |
| Intervention type | Drug |
| Interventions | GSK364735 |
| Enrollment | 30 |
| Start date | Nov 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Nov 10, 2006 |
| Last update posted | Jul 30, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: